<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"></head><body style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;" class=""><a href="https://www.democracynow.org/2021/4/29/jayati_ghosh_priya_sampathkumar_india_vaccines?utm_source=Democracy+Now!&utm_campaign=0d67256f31-Daily_Digest_COPY_01&utm_medium=email&utm_term=0_fa2346a853-0d67256f31-190347269" class="">https://www.democracynow.org/2021/4/29/jayati_ghosh_priya_sampathkumar_india_vaccines</a><div class=""><br class=""></div><div class=""><h1 style="box-sizing: border-box; font-size: 43px; margin: 0px; font-family: TiemposHeadline, Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif; letter-spacing: 0px; line-height: 51.599998474121094px;" class="">How Lifting Intellectual Property Restrictions Could Help World Vaccinate 60% of Population by 2022</h1><div class="row" style="box-sizing: border-box; margin-left: -15px; margin-right: -15px;"><div class="news_label title col-lg-8 col-sm-8" style="box-sizing: border-box; position: relative; min-height: 1px; padding-left: 15px; padding-right: 35px; float: left; width: 760px; text-transform: uppercase; margin-bottom: 10px; caret-color: rgb(25, 31, 36); color: rgb(25, 31, 36); font-family: Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif;"></div><div class="news_label title col-lg-8 col-sm-8" style="box-sizing: border-box; position: relative; min-height: 1px; padding-left: 15px; padding-right: 35px; float: left; width: 760px; text-transform: uppercase; margin-bottom: 10px; caret-color: rgb(25, 31, 36); color: rgb(25, 31, 36); font-family: Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif;"><span class="label" style="box-sizing: border-box; font-size: 14px; font-weight: 800; margin-right: 6px; vertical-align: middle;">STORY</span><span class="date" style="box-sizing: border-box; display: inline; color: rgb(121, 131, 140); opacity: 0.6; font-size: 14px; vertical-align: middle;">APRIL 29, 2021</span><div class="hidden-xs bullet" style="box-sizing: border-box; width: 4px; height: 4px; background-color: rgb(236, 238, 239); margin: 0px 10px; display: inline-block; font-size: 14px; vertical-align: middle;"></div></div></div></div><div class=""><br class=""></div><div class=""><br class=""></div><div class=""><br class=""><div class=""><span style="caret-color: rgb(25, 31, 36); color: rgb(25, 31, 36); font-family: Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 17px; letter-spacing: -0.20000000298023224px; background-color: rgb(255, 255, 255);" class="">As new coronavirus cases surge across India, overwhelming hospitals and crematories, calls are growing louder for wealthy countries to stop hoarding excess supply of </span><span class="caps" style="box-sizing: border-box; caret-color: rgb(25, 31, 36); color: rgb(25, 31, 36); font-family: Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 17px; letter-spacing: -0.20000000298023224px;">COVID</span><span style="caret-color: rgb(25, 31, 36); color: rgb(25, 31, 36); font-family: Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 17px; letter-spacing: -0.20000000298023224px; background-color: rgb(255, 255, 255);" class="">-19 vaccines and to loosen intellectual property restrictions preventing more countries from making their own vaccines. We speak with economist Jayati Ghosh and Congressmember Ro Khanna of California.</span></div><div class=""><div class="text" style="box-sizing: border-box; font-size: 17px; line-height: 27px; letter-spacing: -0.2px; caret-color: rgb(25, 31, 36); color: rgb(25, 31, 36); font-family: Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif;"><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">AMY</span> <span class="caps" style="box-sizing: border-box;">GOODMAN</span>:</strong> We continue on what is happening in India and how it can be dealt with, particularly around the issue of vaccine apartheid and vaccine equity. As the death toll mounts in India, pressure is mounting for the U.S. and other wealthy countries to put an end to vaccine hoarding and share their supply with India and the rest of the world. Top White House adviser Dr. Anthony Fauci addressed the crisis in India, saying, “The only way that you’re going to adequately respond to a global pandemic is by having a global response, and a global response means equity throughout the world.”</p><p style="box-sizing: border-box; margin: 30px 0px;" class="">Calls have also been growing for wealthy members of the World Trade Organization to waive intellectual property rights related to <span class="caps" style="box-sizing: border-box;">COVID</span>-19 vaccines. Earlier this week, Democratic lawmakers and organizations working on this issue held a news conference to deliver a petition, signed by over 2 million people, urging President Biden and the <span class="caps" style="box-sizing: border-box;">WTO</span> to grant the waiver. This is Senator Bernie Sanders.</p><blockquote style="box-sizing: border-box; margin: 0px; padding-left: 30px; border-left-width: 3px; border-left-style: solid; border-left-color: rgb(241, 242, 243);" class=""><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">SEN</span>. <span class="caps" style="box-sizing: border-box;">BERNIE</span> <span class="caps" style="box-sizing: border-box;">SANDERS</span>:</strong> To me, it seems that this is not really a debatable issue. We have the tools to save human lives, and those tools should be readily available to all people. Poor people in Africa, in Asia, Latin America and throughout the world have as much right to be protected from the virus, have as much right to live, as people in wealthier nations. To me, you know, this is not a huge debate. This is common human morality.</p></blockquote><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">AMY</span> <span class="caps" style="box-sizing: border-box;">GOODMAN</span>:</strong> The <span class="caps" style="box-sizing: border-box;">WTO</span> meets again next week to reconsider the waiver.</p><p style="box-sizing: border-box; margin: 30px 0px;" class="">For more, we’re joined by Jayati Ghosh, economics professor at the University of Massachusetts Amherst. She was previously an economics professor at Jawaharlal Nehru University in New Delhi, India, where she taught for 35 years.</p><p style="box-sizing: border-box; margin: 30px 0px;" class="">Thanks so much for joining us, Professor Ghosh. Let’s talk about the causes of this catastrophe in India right now and what vaccine equity looks like, and particularly what the wealthiest country in the world, the United States, should be doing right now.</p><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">JAYATI</span> <span class="caps" style="box-sizing: border-box;">GHOSH</span>:</strong> Well, the catastrophe in India, I would say right now, is actually a man-made catastrophe, because it really reflects a government that had become casual, irresponsible and, in fact, actively engaged in superspreader events. We have had, as was mentioned earlier, massive gatherings, political rallies, addressed by the prime minister and other political leaders, in which all guidelines were flouted.</p><p style="box-sizing: border-box; margin: 30px 0px;" class="">We have had the bringing forward by a full year of a very major Hindu festival on the banks of the Ganges, at which 4 million people participated over the course of three weeks, which, again, is a huge superspreader. And we haven’t even seen the full impact of that. That is going — those people are returning to their homes carrying this disease with them. So we’re going to see much more of that in the rural areas, where there’s absolutely no rural infrastructure for health.</p><p style="box-sizing: border-box; margin: 30px 0px;" class="">So, I think we haven’t seen the worst of it yet. It is beyond horror, what is happening. I have friends and colleagues who have died for lack of oxygen. It’s unbelievable, what is happening. Yet, this is not yet the worst.</p><p style="box-sizing: border-box; margin: 30px 0px;" class="">Obviously, what needs to be done as soon as possible is vaccinate as many people as can be done. There is a shortage of vaccines in India. There is a shortage of vaccines globally. But this is an artificial shortage. This need not happen. There is enough production capacity for vaccines in the world today to vaccinate 60% of the population by the end of this year, the global population, if we waive the intellectual property rights and transfer the knowledge for making these vaccines to all the different producers in different parts of the world who are willing to make it. It’s only these intellectual property rights and this protection of knowledge, which was publicly subsidized, which was actually created by massive public subsidies and prior public research, this — if we waive these and allow the knowledge, we will actually be able to vaccinate significant part of the population and do something about arresting this pandemic. Every day that we do not do this is more lives lost.</p><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">NERMEEN</span> <span class="caps" style="box-sizing: border-box;">SHAIKH</span>:</strong> And, Professor Ghosh, of course, India is home to the world’s largest vaccine manufacturer, the Serum Institute. How is it that the institute has failed to produce larger numbers of vaccines for domestic use?</p><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">JAYATI</span> <span class="caps" style="box-sizing: border-box;">GHOSH</span>:</strong> Well, every company has its own manufacturing capacity. And they have done as much as they can. But it’s ridiculous to expect one company to meet the needs of 1.3 billion people or, in fact, the global population, because they have also many export commitments, to <span class="caps" style="box-sizing: border-box;">COVAX</span> and to other areas. You really have to expand the production. You have to license other producers. This is actually — it’s a no-brainer. It’s so obvious that you cannot rely on the manufacturing capacities of just a few companies.</p><p style="box-sizing: border-box; margin: 30px 0px;" class="">And this is the problem that has actually plagued the entire attitude to vaccine development and production in this pandemic. A few companies have got the rights, and they are holding onto those rights, and they are only producing themselves. They must share this knowledge, and they must allow other producers, because that’s the only way we’re going to confront the crisis. You can’t blame one company and say, “You’re not producing enough.” It’s impossible for one company to produce enough.</p><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">AMY</span> <span class="caps" style="box-sizing: border-box;">GOODMAN</span>:</strong> I mean, we already know this, right? I mean, Biden announced this historic deal between Merck, which didn’t make a vaccine, and Johnson & Johnson, just so that those vaccines could get out there. That was a while ago. But I wanted to ask you, Professor Ghosh, about this back-and-forth. It was an interview with Medicare for All activist, the disability rights activist Ady Barkan. During the 2020 presidential campaign, then-candidate Joe Biden vowed to not let intellectual property barriers prevent other countries from mass-producing <span class="caps" style="box-sizing: border-box;">COVID</span> vaccines. This is part of their exchange.</p><blockquote style="box-sizing: border-box; margin: 0px; padding-left: 30px; border-left-width: 3px; border-left-style: solid; border-left-color: rgb(241, 242, 243);" class=""><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">ADY</span> <span class="caps" style="box-sizing: border-box;">BARKAN</span>:</strong> If the U.S. discovers a vaccine first, will you commit to sharing that technology with other countries? And will you ensure there are no patents to stand in the way of other countries and companies mass-producing those life-saving vaccines?</p></blockquote><blockquote style="box-sizing: border-box; margin: 0px; padding-left: 30px; border-left-width: 3px; border-left-style: solid; border-left-color: rgb(241, 242, 243); padding-top: 30px !important;" class=""><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">JOE</span> <span class="caps" style="box-sizing: border-box;">BIDEN</span>:</strong> Absolutely, positively. This is the only humane thing in the world to do. Were I president now — and I propose we do it now — set aside $25 billion to put together a plan now — now, this instant — how we will distribute that vaccine when it’s made available, to guarantee it gets to every American and access is made available to the rest of the world. … So, the answer is yes. Yes, yes, yes. And it’s not only a good thing to do, it’s overwhelmingly in our interest to do it, as well. Overwhelmingly.</p></blockquote><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">AMY</span> <span class="caps" style="box-sizing: border-box;">GOODMAN</span>:</strong> So, that was candidate Biden. Is he living up to this promise, Professor Ghosh?</p><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">JAYATI</span> <span class="caps" style="box-sizing: border-box;">GHOSH</span>:</strong> So far, unfortunately, not. The U.S. has continued to oppose the <span class="caps" style="box-sizing: border-box;">TRIPS</span> waiver in the <span class="caps" style="box-sizing: border-box;">WTO</span>. I am hoping that the pressure now and the realization that he was absolutely correct in what he said as candidate, that that should actually make the U.S. drop this opposition. It’s really just 14 or 16 countries in the world, the rich countries that are home to Big Pharma companies, that are preventing this from happening. Every other member of the <span class="caps" style="box-sizing: border-box;">WTO</span> is supporting this. So, we really just need them to live up to what they obviously believed in even a few months ago.</p><p style="box-sizing: border-box; margin: 30px 0px;" class="">It’s actually not just a moral imperative — of course, it is — but it is sensible. If you do not contain this virus, you’re going to get these new mutant variants that were talked about, and you will have to have the whole process over again in your own countries. So it’s in the interests of rich country populations to suspend these patents right now.</p><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">NERMEEN</span> <span class="caps" style="box-sizing: border-box;">SHAIKH</span>:</strong> I’d like to bring in Congressmember Ro Khanna into the conversation. He has been leading calls for the U.S. to do more to help countries like India, including to push for this waiver to the <span class="caps" style="box-sizing: border-box;">TRIPS</span> Agreement.</p><p style="box-sizing: border-box; margin: 30px 0px;" class="">Good morning, Congressman Khanna. Could you talk about what’s happening and what you believe the U.S. needs to do now?</p><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">REP</span>. RO <span class="caps" style="box-sizing: border-box;">KHANNA</span>:</strong> Well, thank you, Nermeen.</p><p style="box-sizing: border-box; margin: 30px 0px;" class="">And Professor Ghosh is absolutely right. We have to license this technology so that other countries can produce their vaccine. The argument that the manufacturing capacity isn’t there is simply not accurate. I was speaking to the ambassador of India yesterday. He said that there are 10 production sites ready to manufacture this vaccine. Obviously, we need to invest more in transferring the technical know-how and further building the production capacity, but the main thing is they need to have the vaccine recipe, the formula, to be able to do this.</p><p style="box-sizing: border-box; margin: 30px 0px;" class="">One misconception is this idea that if we have the <span class="caps" style="box-sizing: border-box;">TRIPS</span> waiver, somehow Pfizer or Moderna won’t get paid. That is false. This is not asking these companies to give away their IP for free. What we’re saying is that they need to license it. Compulsory licensing would require compensation. It’s just that they would be able to use the vaccine. Currently, it’s important to understand, they’re not allowing manufacturers to use the vaccine, even manufacturers willing to pay for it. And what we’re saying is, “No, they need to be required to license it.”</p><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">AMY</span> <span class="caps" style="box-sizing: border-box;">GOODMAN</span>:</strong> So, you’re close to — pretty much, to the leadership now, the Democratic leadership, in both houses, also in the White House. What is happening? You heard that interaction where candidate Biden said he absolutely understands this. And that cooperation is happening to develop vaccines in the U.S., like Merck and Johnson & Johnson. So, when will this happen internationally, in terms of the U.S.?</p><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">REP</span>. RO <span class="caps" style="box-sizing: border-box;">KHANNA</span>:</strong> Well, several of us have made it very clear to the administration that we need to do it, we need to be for a <span class="caps" style="box-sizing: border-box;">TRIPS</span> waiver. You’ve had prominent voices, like Joseph Stiglitz, take to <em style="box-sizing: border-box;" class="">The Washington Post</em> op-ed page. Public Citizen has been advocating for this.</p><p style="box-sizing: border-box; margin: 30px 0px;" class="">I think the concern is that these companies — Pfizer, Moderna — have so much power over the distribution of vaccines in the United States, the production of vaccines, that there is some concern, among some corners in the administration, that no one wants to rock the boat with these companies, because, obviously, we want to make sure everything goes smoothly in the United States. But I believe if President Biden gets on the phone with these CEOs and makes the case to them, that they will have to comply. They will continue the production in the United States, and they will actually see that it’s in their long-term strategic interest, with the markets in India and the rest of the world, to, at the very least, temporarily suspend the IP requirements and share the vaccine formula.</p><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">AMY</span> <span class="caps" style="box-sizing: border-box;">GOODMAN</span>:</strong> And, I mean, you have four Indian American congressmembers, right? Ro Khanna, yourself. You have Pramila Jayapal of Washington, just went home, her family infected with <span class="caps" style="box-sizing: border-box;">COVID</span>, came back to this country, said she’s demanding this. You’ve got Ami Bera, who is a doctor from California. And you’ve got Congressmember Krishnamoorthi of Illinois demanding that this happen.</p><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">REP</span>. RO <span class="caps" style="box-sizing: border-box;">KHANNA</span>:</strong> Well, Nermeen, it highlighted to me the importance of representation. I actually never really fully appreciated it until this crisis, but you will see that our voices were one of the first in Congress sounding the alarm of what was happening in India, largely because either having family there or representing constituencies with lots of people who had family there. And I’m glad that the president and Secretary Blinken have taken action now to send oxygen, to send <span class="caps" style="box-sizing: border-box;">PPE</span>, to send essential equipment that India needs. But a lot of it was in response to the activism and the early voices in Congress.</p><p style="box-sizing: border-box; margin: 30px 0px;" class="">Now the key issue is this <span class="caps" style="box-sizing: border-box;">TRIPS</span> waiver, is having the president call these pharmaceutical companies and say, “You’re going to get paid. You’re going to get compensated. In fact, this is in your long-term commercial interest. But you can’t be refusing — you can’t be refusing to license your vaccines.” And that’s what’s going on. And we should be absolutely clear about this. It’s not that they’re asking for money. It’s not that they’re asking for a profit. It’s that they are not willing to license their vaccines. Even making money, even making a profit, they’re not willing to let other countries manufacture it. And that’s just cruel.</p><p style="box-sizing: border-box; margin: 30px 0px;" class=""><strong style="box-sizing: border-box;" class=""><span class="caps" style="box-sizing: border-box;">AMY</span> <span class="caps" style="box-sizing: border-box;">GOODMAN</span>:</strong> We have to break. Then we’re going to go to what happened last night, this historic joint session of Congress that President Biden just addressed. I want to thank our guests, doctor — I want to thank Jayati Ghosh, economics professor at University of Massachusetts Amherst, and Ro Khanna, Democratic congressmember from California, vice chair of the India Caucus in the House, and ask you both to stay with this.</p><div class=""><br class=""></div></div></div><div class=""><br class="webkit-block-placeholder"></div><div class=""><br class="webkit-block-placeholder"></div><div class=""><br class="webkit-block-placeholder"></div><div class="">
Arthur Stamoulis<br class="">Citizens Trade Campaign<br class="">(202) 494-8826<br class=""><br class=""><br class=""><br class="">
</div>
<br class=""></div></body></html>